Ibrutinib provides favourable survival outcomes in patients with comorbidities versus established therapies.
Jan A BurgerPaula CramerPaul M BarrMarie-Sarah DilhuydyAnthony MatoJohn C ByrdStephen ChangThorsten GraefTony LinAlessandra TedeschiPublished in: British journal of haematology (2019)
Keyphrases